The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental Colitis

Various animal models showed that peroxisome proliferator-activated receptor (PPAR)γ agonists, when given as a gavage shortly preceding colitis induction, protect against inflammatory bowel disease (IBD). We have examined the effects of 16 days rosiglitazone treatment via the diet prior to dextran s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramakers, Julian D., Verstege, Marleen I., Thuijls, Geertje, Te Velde, Anje A., Mensink, Ronald P., Plat, Jogchum
Formato: Texto
Lenguaje:English
Publicado: Kluwer Academic Publishers-Plenum Publishers 2007
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1915631/
https://www.ncbi.nlm.nih.gov/pubmed/17510806
http://dx.doi.org/10.1007/s10875-007-9074-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1915631/
https://www.ncbi.nlm.nih.gov/pubmed/17510806
http://dx.doi.org/10.1007/s10875-007-9074-2

Ejemplares similares